The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer

In vitro anticancer activity of fucoidan from Turbinaria conoides against A549 cell lines

(2015) Thangapandi Marudhupandi et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil

(2015) Laura G. M. Daenen et al.   JAMA Oncology

Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradation

(2015) Hsien-Yeh Hsu et al.   Oncotarget

Herb–Drug Interactions in Oncology

(2014) A K L Goey et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Are seaweed-derived fucoidans possible future anti-cancer agents?

(2014) Ray M. Lowenthal et al.   JOURNAL OF APPLIED PHYCOLOGY

Intestinal Absorption of Fucoidan Extracted from the Brown Seaweed, Cladosiphon okamuranus

(2014) Takeaki Nagamine et al.   Marine Drugs

Fucoidan as a Marine Anticancer Agent in Preclinical Development

(2014) Jong-Young Kwak   Marine Drugs

Anti-Metastasis Effect of Fucoidan from Undaria pinnatifida Sporophylls in Mouse Hepatocarcinoma Hca-F Cells

(2014) Peisheng Wang et al.   PLoS One

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

(2013) Ernst A. Lien et al.   BREAST CANCER RESEARCH AND TREATMENT

The effect ofEchinacea purpureaon the pharmacokinetics of docetaxel

(2013) Andrew K. L. Goey et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Protective effect of fucoidan against AAPH-induced oxidative stress in zebrafish model

(2013) Eun-A Kim et al.   CARBOHYDRATE POLYMERS

The Effect of St John’s Wort on the Pharmacokinetics of Docetaxel

(2013) Andrew K. L. Goey et al.   CLINICAL PHARMACOKINETICS

Use of Self-Care and Practitioner-Based Forms of Complementary and Alternative Medicine before and after a Diagnosis of Breast Cancer

(2013) Alissa R. Link et al.   Evidence-based Complementary and Alternative Medicine

Patients with advanced cancer and their usage of complementary and alternative medicine

(2013) Magda Paul et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells

(2013) Hye-Jin Boo et al.   Marine Drugs

Fucoidan Inhibited 4T1 Mouse Breast Cancer Cell Growth In Vivo and In Vitro Via Downregulation of Wnt/β-Catenin Signaling

(2013) Meilan Xue et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer

(2013) Janette Vardy et al.   SpringerPlus

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGF  receptor degradation in breast cancer

(2012) H.-Y. Hsu et al.   CARCINOGENESIS

Individualization of Tamoxifen Treatment for Breast Carcinoma

(2012) L Binkhorst et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: A Systematic Review

(2012) Esther L. Davis et al.   ONCOLOGIST

Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In Vivo

(2012) Meilan Xue et al.   PLoS One

Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways

(2012) Hyunkyoung Lee et al.   PLoS One

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

(2011) Z Desta et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes

(2011) L Madlensky et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women

(2011) Hiromi Tanii et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

How Many Cancer Patients Use Complementary and Alternative Medicine

(2011) Markus Horneber et al.   INTEGRATIVE CANCER THERAPIES

Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment

(2011) Anne-Joy M. de Graan et al.   JOURNAL OF CLINICAL ONCOLOGY

Fucose-Containing Sulfated Polysaccharides from Brown Seaweeds Inhibit Proliferation of Melanoma Cells and Induce Apoptosis by Activation of Caspase-3 in Vitro

(2011) Marcel Tutor Ale et al.   Marine Drugs

Therapies from Fucoidan; Multifunctional Marine Polymers

(2011) Janet Helen Fitton   Marine Drugs

Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer

(2011) MASAHIDE IKEGUCHI et al.   Oncology Letters

Development of a Fucoidan-Specific Antibody and Measurement of Fucoidan in Serum and Urine by Sandwich ELISA

(2010) Yoshiharu TOKITA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Genotoxicity studies on fucoidan from Sporophyll of Undaria pinnatifida

(2010) Kui-Jin Kim et al.   FOOD AND CHEMICAL TOXICOLOGY

Pilot clinical study to evaluate the anticoagulant activity of fucoidan

(2009) Mohammad R Irhimeh et al.   BLOOD COAGULATION & FIBRINOLYSIS

Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review

(2008) Christine M. Velicer et al.   JOURNAL OF CLINICAL ONCOLOGY